Immunodiagnostic Systems (IDS)

Last updated: 07th January, 2020

Immunodiagnostic Systems Holdings (IDS) is a leading in vitro diagnostic solution provider to the clinical laboratory market. IDS develop, manufacture, and market innovative immunoassays and automated immunoanalyser technologies to provide improved diagnostic outcomes for patients. Their immunoassay portfolio is a combination of an endocrinology specialty testing menu and assay panels in complementary fields.

Request a Quote

Request Quote

Go BackGo Back